Pharma
J&J CEO warns against pharmaceutical tariffs
The company expects $400 million in costs this year from already imposed tariffs.
Latest news and analysis on supply chain disruptions from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.